Zhiyan Wang
- Cancer Research top 10%
- MicroRNA in disease regulation 3
- Biochemistry top 10%
-
- Circular RNAs in diseases 3
- Natural product bioactivities and synthesis 2
-
- Cardiac Fibrosis and Remodeling 3
- Cardiovascular Disease and Adiposity 2
- Atrial Fibrillation Management and Outcomes 2
-
- Microbial Natural Products and Biosynthesis 2
-
- Traditional Chinese Medicine Analysis 2
- Co-authors
- Di WangJumo ZhuYi WangHuaner NiBei LiuLili ZhangXueshu ZhangDavid R. Bickers
- Journals
- Advanced Materials (1 paper)SHILAP Revista de lepidopterología (1 paper)Free Radical Biology and Medicine (1 paper)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Zhiyan Wang
35 papers receiving 927 citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Cancer Research 240
- Biochemistry 72
- Immunology 164
- Molecular Biology 491
- Cardiology and Cardiovascular Medicine 137
Countries citing papers authored by Zhiyan Wang
This map shows the geographic impact of Zhiyan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiyan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiyan Wang more than expected).
Fields of papers citing papers by Zhiyan Wang
This network shows the impact of papers produced by Zhiyan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiyan Wang. The network helps show where Zhiyan Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhiyan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 19 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 0 | |
| 11 | 2021 | 17 | |
| 12 | 2020 | 12 | |
| 13 | 2020 | 5 | |
| 14 | 2019 | 86 | |
| 15 | Exosomes from nicotine-stimulated macrophages accelerate atherosclerosis through miR-21-3p/PTEN-mediated VSMC migration and proliferationbreakdown → | 2019 | 326 |
| 16 | 2017 | 5 | |
| 17 | Sjögren's syndrome with extremely elevated plasma alpha-fetoprotein that responded to immunosuppressant treatment. | 2012 | 1 |
| 18 | Isolation and Identification of Genes Related to Astragaloside IV Differential Expressed Synthesis in Astragalus membranaceus | 2005 | 1 |
| 19 | Studies on the chlorophyll fluorescence characteristic of fruit cultivars in ginkgo | 2002 | 3 |
| 20 | 1999 | 121 |
About Zhiyan Wang
Zhiyan Wang is a scholar working on Cardiology and Cardiovascular Medicine, Geriatrics and Gerontology and Complementary and alternative medicine, having authored 39 papers that have together received 947 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Cardiac Fibrosis and Remodeling (3 papers), Circular RNAs in diseases (3 papers), Cardiovascular Disease and Adiposity (2 papers), Microbial Natural Products and Biosynthesis (2 papers), Atrial Fibrillation Management and Outcomes (2 papers), Traditional Chinese Medicine Analysis (2 papers) and Natural product bioactivities and synthesis (2 papers). The work is most often cited by research in Cancer Research (240 citations), Biochemistry (72 citations) and Immunology (164 citations). Zhiyan Wang has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Di Wang, Jumo Zhu, Yi Wang, Huaner Ni, Bei Liu, Yi Wang, Lili Zhang, Lili Zhang, Xueshu Zhang and David R. Bickers. Their work appears in journals such as Advanced Materials, SHILAP Revista de lepidopterología and Free Radical Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.